NEMLUVIO Powder and solvent for solution for injection Ref.[114712] Active ingredients: Nemolizumab

Source: European Medicines Agency (EU)  Revision Year: 2025  Publisher: Galderma International, La Defense 4, Tour Europlaza, 20 Avenue Andre Prothin, 92927 Paris La Defense Cedex, France

Product name and form

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled pen.

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled syringe.

Pharmaceutical Form

Powder and solvent for solution for injection

Powder for solution for injection: lyophilised white powder.

Solvent for solution for injection: A clear, colourless solution.

Qualitative and quantitative composition

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled pen: Each single-use pre-filled pen contains 30 mg of nemolizumab per 0.49 ml dose following reconstitution.

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled syringe: Each single-use pre-filled syringe contains 30 mg of nemolizumab per 0.49 ml dose following reconstitution.

Nemolizumab, a humanised monoclonal modified immunoglobulin G (IgG) antibody, is produced by recombinant DNA technology in Chinese Hamster Ovary cells.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Nemolizumab

Nemolizumab is a humanised IgG2 monoclonal antibody that inhibits interleukin-31 (IL-31) signalling by binding selectively to interleukin-31 receptor alpha (IL-31 RA). IL-31 is a naturally occurring cytokine that is involved in pruritus, inflammation, epidermal dysregulation, and fibrosis. Nemolizumab inhibited IL-31-induced responses including the release of proinflammatory cytokines and chemokines.

List of Excipients

Powder for solution for injection:

Sucrose
Trometamol
Trometamol hydrochloride (for pH-adjustment)
Arginine hydrochloride
Poloxamer 188

Solvent:

Water for injections

Pack sizes and marketing

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled pen:

Single-use dual-chamber borosilicate glass type 1 cartridge in an auto-injector, with a stainless steel staked needle.

Pack size: 1 pre-filled pen, multipack containing 2 (2 packs of 1) pre-filled pens, multipack containing 3 (3 packs of 1) pre-filled pens.

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled syringe:

Single-use dual-chamber pre-filled syringe in a borosilicate glass type 1, co-packaged with a 27G needle (stainless steel) with safety shield.

Pack size: 1 pre-filled syringe

Not all pack sizes may be marketed.

Marketing authorization holder

Galderma International, La Defense 4, Tour Europlaza, 20 Avenue Andre Prothin, 92927 Paris La Defense Cedex, France

Marketing authorization dates and numbers

EU/1/24/1901/001
EU/1/24/1901/002
EU/1/24/1901/003
EU/1/24/1901/004

Drugs

Drug Countries
NEMLUVIO United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.